pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Aug 31·1 min read
save

Verily, NVIDIA and NIH launch first multimodal AI model combining EHR and genomics

Aug 31, 2026·read at BioPharma Dive ↗Positive

Verily Health, in partnership with NVIDIA and the NIH All of Us Research Program, announced the development of a new foundation model that merges electronic health record data with genomic information. The effort aims to create a more comprehensive view of patient health for research and clinical use.

The multimodal model represents the first attempt to integrate these two data streams at scale, building on prior AI work that relied solely on clinical records. By combining genetic insights with routine health data, the system seeks to improve disease risk prediction and support more personalized treatment strategies.

Jonathan Amar, senior manager of Verily Data Science, emphasized that electronic health records capture only one chapter of a patient’s story. He noted that incorporating imaging, genomics and other modalities is essential for AI to fully understand disease risk and advance precision medicine.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “The next frontier: Advancing foundation models with multimodal data”

read at BioPharma Dive ↗
888 words · retrieved Aug 31
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health
drugs
Type 2 Diabetes2H-100
topics
Type 2 Diabetes4OphthalmologyPlatform Company

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Sep 21Novo’s plan to hit $23B in revenue by 2035 leaves investors wantingBioSpace
  • Sep 15Businesses can now apply for NIH fundingSTAT
  • Sep 11Medicaid will let states use ‘tiers’ to determine medical frailtySTAT
  • Aug 11Abbott teams with Google Health on AI-powered health insights appFierce Biotech